Astrea Monts

Form 483 issued June 9, 2015 · Monts, France

Inspection
Jun 1 – Jun 9, 2015
Observations
3
Pages
3
FEI number
1000171152

In short: On June 9, 2015, FDA issued a Form 483 with 3 observations to Astrea Monts in Monts, France (FEI 1000171152) after an inspection that ran Jun 1 – Jun 9, 2015. The investigators were Michael E. Maselli and Nadeem I. Chaudhry. Most observations concern materials and facilities & equipment.

At a glance

Materials and facilities & equipment account for 2 of 3 observations.

Materials1
Facilities & equipment1
Laboratory controls1

What FDA observed

Preview: the opening words of each observation
  1. 01

    There was a failure to handle and store components and drug product containers at all times…

  2. 02

    Equipment for adequate control over micro-organisms is not provided when appropriate for the manufacture, processing, packing…

  3. 03

    Each batch of drug product required to be free of objectionable microorganisms is not tested…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Astrea Monts?

FDA listed 3 observations on this Form 483, mostly about materials, facilities & equipment and laboratory controls. The opening words of each observation are shown on this page.

Who inspected Astrea Monts?

Michael E. Maselli and Nadeem I. Chaudhry are named on this Form 483, for the inspection of Jun 1 – Jun 9, 2015. Each investigator has a profile showing what they cite most.

When was Astrea Monts inspected by FDA?

The inspection ran Jun 1 – Jun 9, 2015, and the Form 483 is dated June 9, 2015.

How do I get the full Form 483 for Astrea Monts?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free